21.09.2024 - 24.09.2024 37th European College of Neuropsychopharmacology (ECNP)
The annual ECNP Congress is Europe’s largest scientific meeting in applied and translational neuroscience, and attracts approximately 6000 healthcare professionals from around the world. Participants have the valuable opportunity to network with other healthcare professionals and share information on the ‘latest discoveries and developments in the science and treatment of brain disorders’.
This year marks the 37th European College of Neuropsychopharmacology (ECNP) Congress and the event will take place over four days from 21 to 24 September in Milan, Italy. The hybrid congress offers a wide variety of scientific sessions that will be available for in-person and virtual participants. A range of scientific sessions are on offer, including industry sessions, symposia, interactive and innovative sessions, posters, and more! Participants can access all online content via the virtual congress platform until 18 December 2024.
Teva will be hosting an Industry Mini Session at ECNP entitled “Do We Live in the Era of Neglecting Tardive Dyskinesia?”. This session will explore current strategies and unmet needs in the screening, diagnosis, and management of tardive dyskinesia (TD). During the session, an expert faculty of psychiatrists will divulge best practices for fostering and empowering conversations with patients living with this disorder. Download an invitation to the Industry Mini Session.
- Click here for more information on ECNP 2024, including any changes to the schedule and venue
Browse below for articles related to the relationship between mental health disorders and migraine.
[Disclaimer: No rights can be derived from the information included on this congress. The content and programme are subject to change – for more information please visit the congress website]
